πŸ‡°πŸ‡ͺ Country Profile

Kenya

Affordable medicine reaching Kenya

πŸ‡°πŸ‡ͺ $427M
All data from DGCIS India export records (fiscal year, April–March).
$427M
Scale
Kenya's healthcare system receives $427M in Indian pharmaceutical products each year β€” affordable, quality medicine.
73%
Medicine
Primarily medicines (73%), supplemented by medicine ingredients and vaccines.
1.7Γ—
Trajectory
India's pharmaceutical supply to Kenya has grown 1.7Γ— over the past decade β€” strong, sustained expansion.
Context
Part of India's pharmaceutical supply network across Africa.
✦
Impact
Indian pharmaceutical companies have both exported to and invested directly in Kenya β€” building trade and operational presence.
Export Trend DGCIS FY
Pharmaceutical Composition Trend DGCIS CY 2014–2025

All pharma categories from DGCIS (487-code basket)

Category Mix — FY 2025–26 DGCIS
Medicines $312M (73.0%) Medicine Ingredients $58.9M (13.8%) Vaccines $44.4M (10.4%) Surgical & Hospital Supplies $7.1M (1.7%) Traditional & Herbal $4.7M (1.1%)
Top Products — FY 2025–26 DGCIS
Indian Pharma Investment in Kenya Source: RBI ODI Data

Total RBI-approved ODI commitments by Indian pharmaceutical companies into Kenya: $6.0M across 17 filings (2011-2025).